Combination therapy

Results: 292



#Item
31Inhaled Steroids What is it? • Inhaled steroids are anti-inflammatory medicines that help prevent asthma symptoms. They help because they reduce inflammation (swelling) and inflammation is a main cause of asthma sympt

Inhaled Steroids What is it? • Inhaled steroids are anti-inflammatory medicines that help prevent asthma symptoms. They help because they reduce inflammation (swelling) and inflammation is a main cause of asthma sympt

Add to Reading List

Source URL: health.utah.gov

Language: English - Date: 2011-01-20 17:49:38
32Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth

Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth

Add to Reading List

Source URL: virginiaasthmacoalition.org

Language: English - Date: 2013-07-11 23:13:34
33FINAL FOR DISTRIBUTION PSIOXUS THERAPEUTICS RAISES A £25M SERIES C INVESTMENT TO PROGRESS ONCOLYTIC VIRUS PLUS CHECKPOINT INHIBITOR COMBINATION STUDY IN METASTATIC COLORECTAL CANCER OXFORD, UK – 19 May 2015 – PsiOxu

FINAL FOR DISTRIBUTION PSIOXUS THERAPEUTICS RAISES A £25M SERIES C INVESTMENT TO PROGRESS ONCOLYTIC VIRUS PLUS CHECKPOINT INHIBITOR COMBINATION STUDY IN METASTATIC COLORECTAL CANCER OXFORD, UK – 19 May 2015 – PsiOxu

Add to Reading List

Source URL: www.psioxus.com

Language: English - Date: 2015-05-19 03:49:40
34Shionogi-ViiV Healthcare Starts Phase III Trial for “572-Trii” Fixed-Dose Combination HIV Therapy London, UK, 3 February 2011 – Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the c

Shionogi-ViiV Healthcare Starts Phase III Trial for “572-Trii” Fixed-Dose Combination HIV Therapy London, UK, 3 February 2011 – Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the c

Add to Reading List

Source URL: shionogi616.tew-staging.com

Language: English - Date: 2014-11-03 11:26:17
35NHLBI Identity Guidelines and Graphic Standards

NHLBI Identity Guidelines and Graphic Standards

Add to Reading List

Source URL: www.nhlbi.nih.gov

Language: English - Date: 2014-04-10 00:23:35
36Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth

Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth

Add to Reading List

Source URL: virginiaasthmacoalition.org

Language: English - Date: 2012-10-30 13:08:40
37Research Intern Scheme in Psychology Dr Lauren McLellan i) Project title. Combination Treatment of Child Anxiety (Combined Cool Kids Treatment Study) ii) Project description. This project is a double-blinded clinical tri

Research Intern Scheme in Psychology Dr Lauren McLellan i) Project title. Combination Treatment of Child Anxiety (Combined Cool Kids Treatment Study) ii) Project description. This project is a double-blinded clinical tri

Add to Reading List

Source URL: www.psy.mq.edu.au

Language: English - Date: 2014-02-24 21:03:23
38COPD INFORMATION PACK What is COPD? ............................................................................. 2 Who gets COPD? .......................................................................... 3 Self Managem

COPD INFORMATION PACK What is COPD? ............................................................................. 2 Who gets COPD? .......................................................................... 3 Self Managem

Add to Reading List

Source URL: www.mhcs.health.nsw.gov.au

Language: English - Date: 2012-10-25 22:37:49
39PLEASE TYPE POLICY TITLE HERE

PLEASE TYPE POLICY TITLE HERE

Add to Reading List

Source URL: www.schn.health.nsw.gov.au

Language: English - Date: 2015-05-29 10:05:54
40Patients at low- to moderate-immunologic risk • Rapamune and Cyclosporine Combination Therapy: One loading dose of 6 mg on day 1, followed by daily maintenance doses of 2 mg (2.1). • Rapamune Following Cyclosporine

Patients at low- to moderate-immunologic risk • Rapamune and Cyclosporine Combination Therapy: One loading dose of 6 mg on day 1, followed by daily maintenance doses of 2 mg (2.1). • Rapamune Following Cyclosporine

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-12-01 14:33:58